| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 5e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |